WallStreetZenWallStreetZen

NASDAQ: LYRA
Lyra Therapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Lyra Therapeutics earnings were -$38.8M for the trailing 12 months ending Jun 30, 2025, with N/A growth year over year. The latest LYRA earnings report on Jun 30, 2025 announced Q2 2025 earnings of -$7.4M, down 13% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, LYRA reported annual earnings of -$93.4M, with 49.1% growth.

LYRA earnings history

Current Revenue
$770.0k
Current Earnings
-$38.8M
Current Profit Margin
-5,043.6%

LYRA Return on Equity

Current Company
-412%
Current Industry
-9.6%
Current Market
31.7%
LYRA's Return on Equity (-412%)... subscribe to Premium to read more.
High Return on Equity Performance

LYRA undefined

Current Company
-61.2%
Current Industry
0%
LYRA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when LYRA announces earnings.

LYRA undefined

Current Company
-93.74%
Current Industry
7.7%
LYRA's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LYRA vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
LYRA-$38.37M-$38.84MN/A-$29.01
LPTX-$64.86M-$65.69MN/A-$1.58
PHIO-$7.09M-$7.09MN/A-$3.25
ARTL-$10.40M-$10.50MN/A-$19.05
BIVI-$16.91M-$17.91MN/A-$12.12
View Top Biotech Stocks

Lyra Therapeutics Earnings Reports & History FAQ

What were Lyra Therapeutics's earnings last quarter?

On LYRA's earnings call on Invalid Date, Lyra Therapeutics (NASDAQ: LYRA) reported Q2 2025 earnings per share (EPS) of -$5.51, up 85.01% year over year. Total LYRA earnings for the quarter were -$7.44 million. In the same quarter last year, Lyra Therapeutics's earnings per share (EPS) was -$36.76.

If you're new to stock investing, here's how to buy Lyra Therapeutics stock.

Is Lyra Therapeutics profitable or losing money?

As of the last Lyra Therapeutics earnings report, Lyra Therapeutics is currently losing money. Lyra Therapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2025 was -$38.84 million, a 61.7% decrease year over year.

What was LYRA's earnings growth in the past year?

As of Lyra Therapeutics's earnings date in Invalid Date, Lyra Therapeutics's earnings has grown year over year. LYRA earnings in the past year totalled -$38.84 million.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.